VYVECLIS Trademark

Trademark Overview


On Tuesday, March 17, 2026, a trademark application was filed for VYVECLIS with the United States Patent and Trademark Office. The USPTO has given the VYVECLIS trademark a serial number of 99707024. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 17, 2026. This trademark is owned by Shionogi & Co., Ltd.. The VYVECLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of infectious diseases, bacterial infection, fungal infection, viral infection, viral diseases, bacteria-based diseases or disorders, allergy, pain, inflammation, inflammatory, sleep disorder, hearing loss, alopecia, obesity, anorexia, diabetes, cognitive disorders, Alzheimer's disease, cancer, oncological diseases, hypertension, anemia, sepsis, blood diseases or disorders, cerebrovascular diseases or disorders, cardiovascular diseases or disorders, endocrine diseases or disorders; Pharmaceutical preparations for the treatment and prevention of musculoskeletal diseases or disorders, cardiopulmonary diseases or disorders, skin diseases or disorders, metabolic diseases or disorders, autoimmune diseases or disorders, immune system related diseases or disorders, urinary diseases or disorders, genitourinary disorders, sexual dysfunction, ocular disorders or diseases, respiratory diseases or disorders, gastrointestinal diseases or ...
vyveclis

General Information


Serial Number99707024
Word MarkVYVECLIS
Filing DateTuesday, March 17, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of infectious diseases, bacterial infection, fungal infection, viral infection, viral diseases, bacteria-based diseases or disorders, allergy, pain, inflammation, inflammatory, sleep disorder, hearing loss, alopecia, obesity, anorexia, diabetes, cognitive disorders, Alzheimer's disease, cancer, oncological diseases, hypertension, anemia, sepsis, blood diseases or disorders, cerebrovascular diseases or disorders, cardiovascular diseases or disorders, endocrine diseases or disorders; Pharmaceutical preparations for the treatment and prevention of musculoskeletal diseases or disorders, cardiopulmonary diseases or disorders, skin diseases or disorders, metabolic diseases or disorders, autoimmune diseases or disorders, immune system related diseases or disorders, urinary diseases or disorders, genitourinary disorders, sexual dysfunction, ocular disorders or diseases, respiratory diseases or disorders, gastrointestinal diseases or disorders, kidney diseases or disorders, hepatological diseases or disorders, hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of central and peripheral nervous system diseases and disorders, neurological diseases and disorders, and psychiatric diseases and disorders; Vaccines; Antivirals; Anti-cancer preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 17, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events


Event DateEvent Description
Tuesday, March 17, 2026NEW APPLICATION ENTERED
Tuesday, March 17, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 17, 2026APPLICATION FILING RECEIPT MAILED